Amino-spiro[oxa(or thia)cycloalkane-penam]-carboxylic acid deriv

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602391, 2603067C, A61K 3143, C07D49944

Patent

active

041396286

ABSTRACT:
Amino-spiro[oxa(or thia)cycloalkane-penam]-carboxylic acid derivatives having the formula ##STR1## WHEREIN X is a sulfur or oxygen atom or the sulfinyl group, n is 1 or 2, m is 1 or 2, R.sub.1 is hydrogen, R.sub.2 is one of the radicals known in the chemistry of the penicillins, preferably 2-phenylacetyl, 2-amino-2-phenylacetyl, 5-methyl-3-phenyl-4-isoxazolecarbonyl or 2,6-dimethoxybenzoyl, or R.sub.1 and R.sub.2 together represent a bivalent radical R.sub.3, preferably (hexahydro-1H-azepin-1-yl)methylene and their therapeutically acceptable non-toxic salts and process for preparing the same.
These compounds have valuable antibacterial properties and are useful as therapeutic agents in the treatment of infectious diseases caused by Gram-positive and Gram-negative bacteria.

REFERENCES:
patent: 2951839 (1960-09-01), Doyle et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amino-spiro[oxa(or thia)cycloalkane-penam]-carboxylic acid deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amino-spiro[oxa(or thia)cycloalkane-penam]-carboxylic acid deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-spiro[oxa(or thia)cycloalkane-penam]-carboxylic acid deriv will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-691595

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.